Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024
CSP
3 min read
9

Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024

November 28, 2024
0

Reading Time: 3 minutes Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate 177Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data

Continue Reading
CSP
7 min read
6

Jetpak Top Holding AB (publ):Interim report 1 January – 30 September 2024

November 28, 2024
0

Reading Time: 5 minutes Third quarter: 1 July – 30 September June 2024  Net revenue increased by 11,7 % to 308 858 (276 583) TSEK Organic growth amounted to 1,7 % (-13,5 %) Gross margin amounted to 28,8 % (29,4 %) Adjusted EBITA amounted to

Continue Reading
Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan
BWI
2 min read
24

Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan

November 28, 2024
0

Reading Time: 2 minutes Dubai, United Arab Emirates:   Keturah, the revolutionary global luxury wellbeing real estate and hospitality concept has announced the launch of a sales campaign for The Ritz-Carlton Residences, Dubai, Creekside—part of the Keturah Resort—and Keturah Reserve which runs until 30 December.  

Continue Reading
CSP
6 min read
13

Leqembi[®] launched in South Korea

November 27, 2024
0

Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult

Continue Reading
CSP
3 min read
16

The Psychology of Online Lottery Bonuses: Insights from LottoRanker

November 27, 2024
0

Reading Time: 2 minutes Stockholm, Sweden – November 2024 — LottoRanker, a trusted authority in the world of online lottery, announces its latest exploration into the psychology behind online lottery bonuses and why they resonate with players. As the digital landscape of lottery gaming continues to

Continue Reading
CSP
1 min read
14

#24-407 Listing of Derivatives at NGM

November 27, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
1 min read
19

#24-408 Delisting of Derivatives from NGM

November 27, 2024
0

Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
3 min read
18

Live Esports Betting: Is it different from Traditional Esports?

November 27, 2024
0

Reading Time: 2 minutes Stockholm, Sweden, November 2024 – eSportsRanker is a leading platform for esports enthusiasts, offering insights, reviews, and expert guidance on the latest trends in esports betting. Today, eSportsRanker is exploring a new way of betting: Live Esports Betting, a dynamic way to

Continue Reading
CSP
10 min read
40

Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million

November 27, 2024
0

Reading Time: 7 minutes Bioretec Ltd Inside information 27 November 2024 at 10.15 p.m. EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN

Continue Reading
CSP
10 min read
10

Spermosens publishes outcome in rights issue

November 27, 2024
0

Reading Time: 7 minutes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION

Continue Reading